A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

Mansoor R Mirza; Dana M Chase; Brian M Slomovitz; René dePont Christensen; Zoltán Novák; Destin Black; Lucy Gilbert; Sudarshan Sharma; Giorgio Valabrega; Lisa M Landrum; Lars C Hanker; Ashley Stuckey; Ingrid Boere; Michael A Gold; Annika Auranen; Bhavana Pothuri; David Cibula; Carolyn McCourt; Francesco Raspagliesi; Mark S Shahin; Sarah E Gill; Bradley J Monk; Joseph Buscema; Thomas J Herzog; Larry J Copeland; Min Tian; Zangdong He; Shadi Stevens; Eleftherios Zografos; Robert L Coleman; Matthew A Powell

doi:10.2217/fon-2023-0940

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, René dePont Christensen, Zoltán Novák, Destin Black, Lucy Gilbert, Sudarshan Sharma, Giorgio Valabrega, Lisa M Landrum, Lars C Hanker, Ashley Stuckey, Ingrid Boere, Michael A Gold, Annika Auranen, Bhavana Pothuri, David Cibula, Carolyn McCourt, Francesco Raspagliesi, Mark S ShahinSarah E Gill, Bradley J Monk, Joseph Buscema, Thomas J Herzog, Larry J Copeland, Min Tian, Zangdong He, Shadi Stevens, Eleftherios Zografos, Robert L Coleman, Matthew A Powell

Department of Oncology

Original language	English
Journal	Future Oncology
Volume	21
Issue number	2
Pages (from-to)	151-168
Number of pages	18
ISSN	1479-6694
DOIs	https://doi.org/10.2217/fon-2023-0940
Publication status	Published - Jan 2025

Keywords

Dostarlimab
Dostarlimab plus chemotherapy
Endometrial cancer
Primary advanced or recurrent endometrial cancer
RUBY

Access to Document

10.2217/fon-2023-0940Licence: CC BY-NC-ND

Cite this

Mirza, M. R., Chase, D. M., Slomovitz, B. M., Christensen, R. D., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., Hanker, L. C., Stuckey, A., Boere, I., Gold, M. A., Auranen, A., Pothuri, B., Cibula, D., McCourt, C., Raspagliesi, F., ... Powell, M. A. (2025). A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer". Future Oncology, 21(2), 151-168. https://doi.org/10.2217/fon-2023-0940

Mirza, MR, Chase, DM, Slomovitz, BM, Christensen, RD, Novák, Z, Black, D, Gilbert, L, Sharma, S, Valabrega, G, Landrum, LM, Hanker, LC, Stuckey, A, Boere, I, Gold, MA, Auranen, A, Pothuri, B, Cibula, D, McCourt, C, Raspagliesi, F, Shahin, MS, Gill, SE, Monk, BJ, Buscema, J, Herzog, TJ, Copeland, LJ, Tian, M, He, Z, Stevens, S, Zografos, E, Coleman, RL & Powell, MA 2025, 'A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"', Future Oncology, vol. 21, no. 2, pp. 151-168. https://doi.org/10.2217/fon-2023-0940

@article{b20c6d66fb054f04b59dd730c7c5fd5d,

title = "A Plain Language Summary of {"}Dostarlimab for primary advanced or recurrent endometrial cancer{"}",

keywords = "Dostarlimab, Dostarlimab plus chemotherapy, Endometrial cancer, Primary advanced or recurrent endometrial cancer, RUBY",

author = "Mirza, {Mansoor R} and Chase, {Dana M} and Slomovitz, {Brian M} and Christensen, {Ren{\'e} dePont} and Zolt{\'a}n Nov{\'a}k and Destin Black and Lucy Gilbert and Sudarshan Sharma and Giorgio Valabrega and Landrum, {Lisa M} and Hanker, {Lars C} and Ashley Stuckey and Ingrid Boere and Gold, {Michael A} and Annika Auranen and Bhavana Pothuri and David Cibula and Carolyn McCourt and Francesco Raspagliesi and Shahin, {Mark S} and Gill, {Sarah E} and Monk, {Bradley J} and Joseph Buscema and Herzog, {Thomas J} and Copeland, {Larry J} and Min Tian and Zangdong He and Shadi Stevens and Eleftherios Zografos and Coleman, {Robert L} and Powell, {Matthew A}",

year = "2025",

month = jan,

doi = "10.2217/fon-2023-0940",

language = "English",

volume = "21",

pages = "151--168",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

AU - Mirza, Mansoor R

AU - Chase, Dana M

AU - Slomovitz, Brian M

AU - Christensen, René dePont

AU - Novák, Zoltán

AU - Black, Destin

AU - Gilbert, Lucy

AU - Sharma, Sudarshan

AU - Valabrega, Giorgio

AU - Landrum, Lisa M

AU - Hanker, Lars C

AU - Stuckey, Ashley

AU - Boere, Ingrid

AU - Gold, Michael A

AU - Auranen, Annika

AU - Pothuri, Bhavana

AU - Cibula, David

AU - McCourt, Carolyn

AU - Raspagliesi, Francesco

AU - Shahin, Mark S

AU - Gill, Sarah E

AU - Monk, Bradley J

AU - Buscema, Joseph

AU - Herzog, Thomas J

AU - Copeland, Larry J

AU - Tian, Min

AU - He, Zangdong

AU - Stevens, Shadi

AU - Zografos, Eleftherios

AU - Coleman, Robert L

AU - Powell, Matthew A

PY - 2025/1

Y1 - 2025/1

KW - Dostarlimab

KW - Dostarlimab plus chemotherapy

KW - Endometrial cancer

KW - Primary advanced or recurrent endometrial cancer

KW - RUBY

UR - http://www.scopus.com/inward/record.url?scp=85198539077&partnerID=8YFLogxK

U2 - 10.2217/fon-2023-0940

DO - 10.2217/fon-2023-0940

M3 - Journal article

C2 - 38990090

SN - 1479-6694

VL - 21

SP - 151

EP - 168

JO - Future Oncology

JF - Future Oncology

IS - 2

ER -

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

Keywords

Access to Document

Other files and links

Cite this